Relationship Between Glycemic Control and Irisin in Type 2 Diabetic Patients With Sarcopenic or Non-sarcopenic Obesity
Recruiting
Observational Study
Sarcopenia
Obesity
Diabetes Mellitus, Type 2
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 60 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to compare glycemic control and irisin levels in subjects with diabetes mellitus type 2 with sarcopenic obesity vs non-sarcopenic obesity.
The main questions it aims to answer are:
Is glycemic control worse in diabetic patients with sarcopenic obesity? Are irisin levels higher in patients with non-sarcopenic obesity?
Participants will be asked to:
* Fill…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diabetes mellitus type 2 diagnosed less than 10 years before
* age \>60 years
* BMI (Body Mass Index) \>30 kg/m2
* eGFR (estimated Glomerular Filtration Rate) \>30 ml/min
* On stable antidiabetic therapy for at least 3 months
Exclusion Criteria:
* Insulin or insulin secretag…
Contacts